FAQs

Partnership between biopharmaceutical, health tech or MedTech companies and patient organisations, in the fields of patient advocacy, communications, market access, clinical trials or research and development can be submitted to the Index. Partnerships activity must have taken place within the last two years, and can be at UK or above country (regional or global) level.

Entries are welcome from any biopharmaceutical, health tech or MedTech company, or any patient organisation involved in an eligible partnership. All members of a partnership should agree to the submission of an entry to the Index.

Yes you can. We actively encourage joint submissions from life sciences companies and the patient organisation they have partnered with.

If multiple companies or patient organisations have collaborated on a project, please submit the entry under the name of the lead organisation or an agreed contact.

We only accept entries from partners who have participated in the project, and cannot accept entries from those representing these partners, for example agencies.

Partners are able to enter up to three entries overall, showcasing patient partnerships at a UK or above country level. These can be all UK partnerships, all above country partnerships, or a mixture of the two. Entries can be submitted by the company or patient organisation involved in the partnership.

Entries must be made in the English language, using the entry form provided on registration. It is your responsibility to get the permission of the other partner(s) involved before submitting.

Patient advocacy, communications, and market access as well as clinical trials and research and development projects can be submitted to the Index.

Yes you can! Entering in one year will not stop you from being allowed to enter the next year. In fact, you might find a previous entry has strengthened over time and so it may even be the same project!

Yes. The communications and advocacy partnership project with patient organisations you use in your entry must be in progress or ongoing, or have ended in the last 2 years.

Entries for the 2024 Patient Partnership Index close at 23:55pm on Friday 26^th April.

No. The Patient Partnership Index is run by OVID Health on a completely pro bono basis, to celebrate and recognise best practice partnerships between biopharmaceutical companies and patient organisations.

You can update the patient organisation testimonial part ONLY. This update will have to be submitted via email. Please note that though we accept updated testimonials, we cannot guarantee these updates will be made.

In the case of genuine administrative errors, we will allow updates on a case-by-case basis.

If you need technical help with your entry, or have any questions not addressed in this FAQ, please email info@patientpartnershipindex.com.

No additional supporting information will be shared with the judging panel.

Entries will not be ranked. Entries that meet the highest standard will be awarded a GOLD standard and entries that are close will receive a SILVER. Entries that are included in the Index will be awarded FINALIST standard.

GOLD, SILVER and FINALIST standards will be awarded by a panel of independent expert judges using a bespoke metric developed in partnership with industry and patient organisations.

Judges will be able to see the names of companies and patient organisations involved in the project. Judges will sign a confidentiality agreement that prevents them from discussing entries outside of the judging sessions or sharing any of the materials submitted. Judges who declare a conflict of interest in relation to a company’s entry will not judge those entries.

Some parts of entries may be commercially sensitive but only the judges (and PPI team) will see the entries and will not publish any sections of your entries marked ‘commercially sensitive’.

Yes. We will provide you with graphics if you are awarded GOLD, SILVER or FINALIST standard, and even just for entering!

The Patient Partnership Index is a pro bono initiative from OVID Health to celebrate and recognise best practice partnerships between biopharmaceutical companies and patient organisations. You can find out more about us via the contact page on this website.

Your data will be used by OVID Health (a trading name of Ovid Consulting Ltd) any direct contractors/subsidiaries for the purposes of administering and promoting the Patient Partnership Index.

Award entries will be shared with the judging panel, but we will not sell or share your data with any third parties. Additionally, you may opt-in to receive other information from OVID Health from which you can unsubscribe at any time.

By entering you allow OVID Health to use your award submission, logo(s), image(s), organisation information, and any other materials submitted in conjunction with the Patient Partnership Index. This may include publishing online or in print, as well as editing, re-use and dissemination on social media. We will not publish your contact details without your permission.

Entries remain the intellectual property of the company submitting them.

The Index is a good faith effort to award excellence in patient partnerships, not a data harvesting exercise. If you have any questions, please email us.